See also this year's filing and all EDGAR filings for this company.
PDF Report 0001003642_2018_Impax_Laboratories_LLC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.1537255170852196, 'aggregate_val': 1447051000, 'exp_sum': 1254242000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 535123000, 'SellingGeneralAndAdministrativeExpense': 216270000, 'ResearchAndDevelopmentExpense': 80847000, 'remainder_Expenses': 422002000}} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001003642')"} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001003642, Impax Laboratories LLC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 695,555,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 469,796,000 |
| 2 | PropertyPlantAndEquipmentNet | 124,813,000 |
| 3 | remainder_Assets | 61,136,000 |
| 4 | LiabilitiesCurrent | 354,238,000 |
| 5 | LiabilitiesNoncurrent | 806,635,000 |
| 6 | remainder_Liabilities | 3,226,000 |
| 7 | CostOfGoodsAndServicesSold | 535,123,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 216,270,000 |
| 9 | ResearchAndDevelopmentExpense | 80,847,000 |
| 10 | remainder_Expenses | 614,811,000 |
| 11 | remainder_Revenues | 775,787,000 |
| 12 | remainder_NetIncome | 9,142,000 |
| 13 | remainder_ComprehensiveNetIncome | 9,285,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,351,300,000 |
| 1 | Liabilities | 1,164,099,000 |
| 2 | Expenses | 1,447,051,000 |
| 3 | Revenues | 775,787,000 |
| 4 | StockholdersEquity | 187,201,000 |
| 5 | NetIncome | -662,122,000 |
| 6 | ComprehensiveNetIncome | -657,479,500 |
| 7 | BaseVar | 2,378,332,000 |
| 8 | EconomicCapitalRatio | -0.267 |
Edgar->Model Mapping
Feature Distribution
Change over Time
